Article
Optimized creation of glioblastoma patient derived xenografts for use in preclinical studies.
Journal of translational medicine - 9 Feb 2017
William Doreen, Mullins Christina Susanne, Schneider Björn, Orthmann Andrea, Lamp Nora, Krohn Mathias, Hoffmann Annika, Classen Carl-Friedrich, Linnebacher Michael
Abstract excerpt
BACKGROUND: Glioblastoma multiforme (GBM) is the most common and lethal brain tumor in adults, highlighting the need for novel treatment strategies. Patient derived xenografts (PDX) represent a valuable tool to accomplish this task. METHODS: PDX were established by implanting GBM tissue subcutaneously. Engraftment success was compared between NMRI Foxn1nu and NOD/SCID as well as between fresh and cryopreserved...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
